(3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium has been researched along with B16 Melanoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harris, DT; Tsang, TC; Zhang, T | 1 |
1 other study(ies) available for (3-dimyristyloxypropyl)(dimethyl)(hydroxyethyl)ammonium and B16 Melanoma
| Article | Year |
|---|---|
Comparison of cis and trans tat gene expression in HIV LTR-based amplifier vectors.
Topics: Animals; Cytomegalovirus; Fibroblasts; Gene Expression Regulation, Viral; Gene Products, tat; Genes, Reporter; Genes, Synthetic; Genes, tat; Genetic Therapy; Genetic Vectors; HIV Long Terminal Repeat; HIV-2; Humans; Interleukin-2; Jurkat Cells; Lipids; Melanoma, Experimental; Mice; Promoter Regions, Genetic; Quaternary Ammonium Compounds; Recombinant Fusion Proteins; tat Gene Products, Human Immunodeficiency Virus; Transfection | 2002 |